PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA.
- Resource Type
- Article
- Source
- HemaSphere; 2023 Supplement 3, Vol. 7, p1-4, 4p
- Subject
- Language
- ISSN
- 25729241